ASH 2010 Update on Non-Hodgkin Lymphoma: Alignment of the Current Treatment Landscape and Value-Based Care

Target Audience
This activity was developed for pharmacists and other healthcare professionals practicing in a managed care environment.

Learning Objectives
Upon completion of this activity, the participant will be able to:

• Explain the impact of key clinical data presented at ASH 2010 on payers and providers in the treatment and management of non-Hodgkin lymphoma (NHL)
• Identify patient/disease-associated factors, as well as economic factors that may affect the choice of a therapeutic agent and be able to formulate a management strategy using a risk-adapted approach to the treatment of NHL
• Construct informed treatment decisions for the purpose of improving the long-term outlook for patients with NHL across the lifecycle of the disease
• Identify and discuss the future of NHL treatment and the potential clinical, business, and regulatory changes that could affect the benefit design cost-value

Pharmacists Designation
Medical Learning Institute (MLI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Completion of this activity provides for 1.0 contact hour (0.1 CEU) of continuing education credit. The universal activity number for this activity is 0468-9999-11-003-H01-P.

Instructions for Credit
There is no fee for this activity. To receive credit, participants must first take the pretest for this activity. After reading this CE activity in its entirety, participants must complete the posttest and evaluation. The pretest, posttest, and evaluation can be completed online at www.mlicme.org/p11008.html. Upon completion of the evaluation and scoring a 70% or better on the posttest, you will immediately receive your certificate online. If you do not achieve a score of 70% or better on the posttest, you will be asked to take it again. Please retain a copy of the Certificate for your records.

For questions regarding the accreditation of this activity, please contact Medical Learning Institute at (609) 333-1693 or cgusack@mlicme.org.

Faculty Disclosures
Before the activity, all faculty will disclose the existence of any financial interest and/or relationship(s) they might have with the manufacturer(s) of any commercial product(s) to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speaker’s bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions.

John Fox, MD, and James T. Kenney, RPh, MBA, have nothing to disclose.

Caroline Helwick has stock ownership at Micronet.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and Center of Excellence Media, LLC, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CE activity for any amount during the past 12 months.

Disclaimer
The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a  healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.